These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PAX2 expression in Wilms tumors and other childhood neoplasms. Davis JL; Matsumura L; Weeks DA; Troxell ML Am J Surg Pathol; 2011 Aug; 35(8):1186-94. PubMed ID: 21730820 [TBL] [Abstract][Full Text] [Related]
3. PAX immunoreactivity in poorly differentiated small round cell tumors of childhood. Fan R Fetal Pediatr Pathol; 2014 Aug; 33(4):244-52. PubMed ID: 24897005 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of cyclin D1 in the diagnosis of small round blue cell tumors in children and adolescents. Magro G; Salvatorelli L; Alaggio R; D'Agata V; Nicoletti F; Di Cataldo A; Parenti R Hum Pathol; 2017 Feb; 60():58-65. PubMed ID: 27984122 [TBL] [Abstract][Full Text] [Related]
5. Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype. Heerema-McKenney A; Wijnaendts LC; Pulliam JF; Lopez-Terrada D; McKenney JK; Zhu S; Montgomery K; Mitchell J; Marinelli RJ; Hart AA; van de Rijn M; Linn SC Am J Surg Pathol; 2008 Oct; 32(10):1513-22. PubMed ID: 18708938 [TBL] [Abstract][Full Text] [Related]
6. Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens. Hostein I; Andraud-Fregeville M; Guillou L; Terrier-Lacombe MJ; Deminière C; Ranchère D; Lussan C; Longavenne E; Bui NB; Delattre O; Coindre JM Cancer; 2004 Dec; 101(12):2817-24. PubMed ID: 15536621 [TBL] [Abstract][Full Text] [Related]
7. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas. Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488 [TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic analysis consistently identifies translocations involving chromosomes 1, 2 and 15 in five embryonal rhabdomyosarcoma cell lines and a PAX-FOXO1A fusion gene negative alveolar rhabdomyosarcoma cell line. Roberts I; Gordon A; Wang R; Pritchard-Jones K; Shipley J; Coleman N Cytogenet Cell Genet; 2001; 95(3-4):134-42. PubMed ID: 12063389 [TBL] [Abstract][Full Text] [Related]
9. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755 [TBL] [Abstract][Full Text] [Related]
10. ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status. Corao DA; Biegel JA; Coffin CM; Barr FG; Wainwright LM; Ernst LM; Choi JK; Zhang PJ; Pawel BR Pediatr Dev Pathol; 2009; 12(4):275-83. PubMed ID: 18788887 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies. Azorsa DO; Bode PK; Wachtel M; Cheuk ATC; Meltzer PS; Vokuhl C; Camenisch U; Khov HL; Bode B; Schäfer BW; Khan J Mod Pathol; 2021 Apr; 34(4):748-757. PubMed ID: 33299109 [TBL] [Abstract][Full Text] [Related]
12. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326 [TBL] [Abstract][Full Text] [Related]
13. PAX-5: a valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms. Desouki MM; Post GR; Cherry D; Lazarchick J Clin Med Res; 2010 Jul; 8(2):84-8. PubMed ID: 20660931 [TBL] [Abstract][Full Text] [Related]
14. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Davicioni E; Finckenstein FG; Shahbazian V; Buckley JD; Triche TJ; Anderson MJ Cancer Res; 2006 Jul; 66(14):6936-46. PubMed ID: 16849537 [TBL] [Abstract][Full Text] [Related]
15. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Barr FG Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823 [TBL] [Abstract][Full Text] [Related]
16. C-kit expression in pediatric solid tumors: a comparative immunohistochemical study. Smithey BE; Pappo AS; Hill DA Am J Surg Pathol; 2002 Apr; 26(4):486-92. PubMed ID: 11914627 [TBL] [Abstract][Full Text] [Related]
17. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of nestin expression in pediatric tumors in the region of the kidney. Murphy AJ; Viero S; Ho M; Thorner PS Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):517-23. PubMed ID: 19417621 [TBL] [Abstract][Full Text] [Related]
20. PAX5 expression in nonhematopoietic tissues. Reappraisal of previous studies. Morgenstern DA; Hasan F; Gibson S; Winyard P; Sebire NJ; Anderson J Am J Clin Pathol; 2010 Mar; 133(3):407-15. PubMed ID: 20154279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]